Artificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults

Recruiting Observational Study
Melanoma (Skin Cancer) Artificial Intelligence (AI) Pediatric Cancer
Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
3,000 (estimated)
Sponsor
German Cancer Research Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this study is to develop supportive diagnostic artificial intelligence algorithms to distinguish melanoma from nevi or other benign pigmented skin lesions, especially in younger patients (below the age of 30). The main goals it aims to achieve are: * development of an algorithm based on dermatoscopic images, targeting skin cancer screening in vulnerable populations * development of an…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: \- Exclusion Criteria: * Patients without a melanoma or nevus diagnosis * images with insufficient image quality
Contacts

Titus J Brinker, PD Dr. med

+49 15175084347

titus.brinker@nct-heidelberg.de

CONTACT